At Yarrow, we are driven by the spirit of innovation and the quest for excellence.
We are committed to advancing safe and effective biological discoveries, bridging the gap between cutting-edge research and real-world solutions, and bringing hope to those who need it most.
Our lead program is for the treatment of autoimmune disease with the potential to be the first- and best-in-class disease-modifying therapy in multiple indications.
Company Details
- Employees
- 9
- Founded
- 2021
- Address
- 101 Avenue Of The Americas,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.yarrowbio.com/
- HQ
- New York, NY
Yarrow Biotechnology, Inc Questions
Yarrow Biotechnology, Inc's website is https://www.yarrowbio.com/
Yarrow Biotechnology, Inc's LinkedIn profile is https://www.linkedin.com/company/yarrow-bio
Yarrow Biotechnology, Inc has
9 employees.
View email and phone details for 9
employees at Yarrow Biotechnology, Inc.
Yarrow Biotechnology, Inc's industry is
Biotechnology Research
Yarrow Biotechnology, Inc's top competitors are
Volastra Therapeutics,
Longevity Biotechnology Association,
Khaya Biosciences,
Enceladus Bio,
Gameto,
Center For Research Innovation In Biotechnology (Crib),
Rtw Investments, Lp,
C16 Biosciences,
Élan Vital Health & Biotechnology,
Prolab Biotechnology.
Yarrow Biotechnology, Inc's categories are Biotechnology Research
Yarrow Biotechnology, Inc's founding year is 2021
